2018. Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S18. DOI:https://doi.org/10.25251/skin.2.supp.18.